GSK researches, develops, manufactures, and commercializes medicines and vaccines, with key focus areas including respiratory diseases, oncology, HIV, and infectious disease prevention. Its products are supplied through healthcare professionals and public health programs to patients and populations in numerous countries. The company invests substantially in research and development to advance its pharmaceutical and vaccine pipelines.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 7,986 | — | 1,443 | -17.7% |
| Q3 2025 | 8,547 | — | 2,013 | -1.3% |
| Q4 2025 | 8,618 | — | 636 | -32.2% |
| Q1 2026 | 7,629 | — | 1,737 | -5.1% |
| Q2 2026 | 8,409 | 5.3% | 435 | -69.8% |
All markets — KeepWinning global stock screener
Other companies on London Stock Exchange: Glencore plc (GLEN), Barclays PLC (BARC), Lloyds Banking Group plc (LLOY), BAE Systems plc (BA), National Grid plc (NG), NatWest Group plc (NWG)